Clinical trials
Pathologic Processes trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AusperBio Therapeutics Inc. | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Eli Lilly and Company | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Neuroscience Trials Australia | 1 |
| Novartis Pharmaceuticals | 1 |
| Olympus Corporation of the Americas | 1 |
| Second Affiliated Hospital of Wenzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Processes | 9 |
| Lung Diseases | 3 |
| Respiratory Tract Diseases | 3 |
| Autoimmune Diseases | 2 |
| Immune System Diseases | 2 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Arthritis | 1 |
| Blood-Borne Infections | 1 |
Trials
Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.